Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: The present invention provides: ferritin; a single-chain variable fragment bound to the N-terminus of the ferritin; and a fusion protein self-assembling nanoparticle structure in which an N-terminus RNA-interaction domain (RID) in a human-derived lysyl-tRNA synthetase is bound to the N-terminus of the single-chain variable fragment by means of a novel fusion partner. Therefore, the present invention provides: a fusion protein having enhanced water solubility; nanoparticles; a vector coding same; a host cell transformed by means of the vector, and a pharmaceutical composition, for treating a disease, using the same.

Abstract: The present disclosure provides: a compound of a specific chemical structure, having excellent activity with respect to BTK degradation; or a pharmaceutically acceptable salt thereof. The present disclosure also provides a composition comprising the compound or pharmaceutically acceptable salts thereof. The present disclosure also provides are pharmaceutical use for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer) of the compound, the salt thereof, and the composition comprising same according to the present disclosure. The present disclosure also provides a method for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer), comprising administering, to a subject requiring treatment, an effective amount of the compound, the salt thereof, or the composition comprising same according to the present disclosure.

Abstract: Proposed are a freight replacement apparatus and a freight replacement method. According to an embodiment of the present disclosure, the freight replacement apparatus includes an automated loading part configured to load thereon a first freight and to move to a designated position, a transporting part configured to load thereon a second freight different from the first freight and to transfer the second freight, a buffer part disposed between the automated loading part and the transporting part, and a replacement part configured to replace the first freight and the second freight together with the buffer part. Therefore, damage to freight may be prevented, and a replacement speed between different freights may be increased.

Abstract: A water purifier includes: a water outlet unit; a water temperature sensor; a filter; a cold water module for cooling the purified water to provide cold water; a hot water module including a heater for heating water, and a hot water body providing a space which receives the hot water or through which the hot water flows; a flow channel connected to the water outlet unit, the filter, the cold water module, and the hot water module to provide a passage through which the purified water, the cold water, the hot water, and discharge water flow; a valve module that are selectively opened/closed to control the flow of water in the flow channel; and a controller for controlling the valve module such that a temperature of the water discharged from the water outlet unit measured by the water temperature sensor is a target temperature.

Abstract: The present invention relates to a compound having TrkA inhibitory activity and a pharmaceutical composition for preventing or treating pain containing the same as an active ingredient. The compound provided in one aspect of the present invention has excellent TrkA inhibitory activity and exhibits excellent pain inhibitory effects in an animal model of pain after a surgery, and thus can be effectively used as an analgesic.

Abstract: An etching composition providing a high selection ratio enabling selective removal of a nitride film and minimization of an etching rate, a preparation method thereof, an etching composition additive prepared through a reaction of phosphoric anhydride and a silane compound represented by Formula 1 below, a method for preparing the same and an etching composition including the same are provided:

Abstract: An etchant composition includes phosphoric acid and a silane compound represented by the following Chemical Formula 1: wherein A is an n-valent radical, L is C1-C5 hydrocarbylene, R1 to R3 are independently hydrogen, hydroxy, hydrocarbyl, or alkoxy, in which R1 to R3 exist respectively or are connected to each other by a heteroelement, and n is an integer of 2 to 5.

Abstract: An etching composition providing a high selection ratio enabling selective removal of a nitride film and minimization of an etching rate, a preparation method thereof, an etching composition additive prepared through a reaction of phosphoric anhydride and a silane compound represented by Formula 1 below, a method for preparing the same and an etching composition including the same are provided:

Abstract: Provided is a method for producing poly(alkylene carbonate)polyol, and specifically, a method for producing poly(alkylene carbonate)polyol having carbonate, ester, and ether bonds by mixing a Salen-based catalyst and a double metal cyanide catalyst.

Abstract: An etchant composition includes phosphoric acid and a silane compound represented by the following Chemical Formula 1: wherein A is an n-valent radical, L is C1-C5 hydrocarbylene, R1 to R3 are independently hydrogen, hydroxy, hydrocarbyl, or alkoxy, in which R1 to R3 exist respectively or are connected to each other by a heteroelement, and n is an integer of 2 to 5.

Abstract: Provided is a polyalkylene carbonate resin composition having high thermal resistance including: polyalkylene carbonate obtained by reacting carbon dioxide with one or two or more different epoxide compound(s) selected from the group consisting of C2-C10 alkylene oxide unsubstituted or substituted with halogen or alkoxy, C4-C20 cycloalkylene oxide unsubstituted or substituted with halogen or alkoxy, and C8-C20 styrene oxide unsubstituted or substituted with halogen, alkoxy, alkyl or aryl; an epoxy resin; and a curing agent.

Abstract: Provided are a double metal cyanide (DMC) catalyst used in copolymerization of an epoxide/carbon dioxide useful for preparing polyurethane, a foaming agent, an elastomer, sealant, a coating material, and the like, and an epoxide/carbon dioxide copolymer prepared using the same. In addition, the present invention provides a double metal cyanide (DMC) catalyst prepared using an ion-exchange resin without washing alcohol, and an epoxide/carbon dioxide copolymer having a high purity, a high selectivity, and a high carbonate content prepared using the same.

Abstract: The present invention is directed to a novel complex synthesized from a Salen-type ligand. The novel complex contains a quaternary ammonium salt. The present invention is also directed to a preparation method of a copolymer of carbon dioxide and epoxide using the complex synthesized from a Salen-type ligand as a catalyst.

Abstract: Provided is a method for producing poly(alkylene carbonate)polyol, and specifically, a method for producing poly(alkylene carbonate)polyol having carbonate, ester, and ether bonds by mixing a Salen-based catalyst and a double metal cyanide catalyst.

Abstract: The present invention relates to a torque sensor cover. According to an embodiment of the present invention, as a second cover is formed of plastic through injection-molding, costs and weight can be reduced as compared with a wire cover manufactured of aluminum through casting according to the related art.

Abstract: The present invention is directed to a novel complex synthesized from a Salen-type ligand. The novel complex contains a quaternary ammonium salt. The present invention is also directed to a preparation method of a copolymer of carbon dioxide and epoxide using the complex synthesized from a Salen-type ligand as a catalyst.

Abstract: The present invention relates to a novel function of Msx1 protein for inhibiting tumor angiogenesis and metastasis by targeting mTOR (mammalian target of rapamycin) signaling pathway, and for treating a cancer in a subject. Particularly, Msx1 suppresses mTOR through a direct interaction with mTOR, resulting in the inhibition of angiogenesis. The Msx1 significantly suppresses tumor angiogenesis that is necessary for the growth, invasion, and metastasis of solid tumors. Ad-Msx1 can be used to effectively inhibit tumor metastasis by suppressing angiogenesis, tumor cell invasion, and migration.